Press Releases and Announcements

December 15, 2020 Shaping the Future of Biopharma through Next-Generation Contract Drug Manufacturing

CEO Frank Mathias’ cover feature in Pharma’s Almanac

December 1, 2020 Diana Wiedmann, new Senior Vice President Human Relations, responsible for global strategic development of human relations

Highly qualified team of three are taking the lead at Rentschler Biopharma’s HR department

November 2, 2020 Biopharmaceuticals: Benefits for patients with autoimmune diseases

Targeted therapy, smart devices and patient support programs ensure patient well-being and benefit society at large

October 22, 2020 Benefits of combining bioinformatics and an algorithm- and database-driven approach for biopharmaceutical stabilization

Article on how we maximize API potential for clients via our strategic alliance with Leukocare

October 19, 2020 Entrepreneurial success driven by vision and freedom

An Interview about Rentschler Biopharma’s history and future

October 14, 2020 Rentschler Biopharma and ATUM announce Leap-In Transposase® licensing agreement

Technology will be integrated into Rentschler Biopharma’s in-house process with a fast, cost-effective, and stable platform to complement existing CLD offering

October 7, 2020 Joining forces against SARS-CoV-2

Rentschler Biopharma contributes to manufacturing of COVID-19 mRNA vaccine

October 1, 2020 Sustainable value creation and a spirit of innovation

CEO Frank Mathias featured in in this year’s Biotechnology issue of Plattform Life Sciences.

September 30, 2020 Collaboration and continuous optimization: Cornerstones of our strategy

Article on our strategic collaboration with Vetter Pharma and insights on our COVID-19 response in Pharma’s Almanac latest issue

September 17, 2020 “A wonderful match”: Vetter and Rentschler Biopharma strategic collaboration

BioPharma Cluster South Germany Interview

September 15, 2020 We share the same DNA

Rentschler Biopharma and Vetter cooperate to accelerate biopharmaceutical manufacturing

August 17, 2020 Rentschler Biopharma optimizes time-to-market for life-saving biopharmaceuticals

Detailed capabilities review published in the latest BPI Industry Innovators Issue

July 20, 2020 Competitive advantages of a family-owned business

Flexible decision-making leads to sustainable value creation

July 16, 2020 Rentschler Biopharma’s expansion plans at U.S. site driven by an innovative business model

Interview with Federico Pollano, SVP Global BD

July 15, 2020 Process intensification strategy accelerates upstream bioprocess development by one third

Application of an intensified seed train and dynamic feeding strategies leads to reduced timelines and higher product yields

July 6, 2020 The key to tackling drug development complexity: Collaboration.

Rentschler Biopharma and Vetter team up with joint goal to simplify processes and optimize time-to-market

July 1, 2020 Medical Biotechnology in Germany 2020

The German biotech landscape holds immense potential for advanced therapy medicinal products.

June 17, 2020 Rentschler Biopharma SE appoints Alexander Dettmer as Chief Financial Officer

Alexander Dettmer will head the finance, supply chain management, legal and information technology functions

May 27, 2020 Extending Collaboration with Genmab to U.S. facility

Innovative agreement provides flexible model to address Genmab’s development and manufacturing needs as programs advance in development

May 25, 2020 United we are stronger

Cooperation in times of COVID-19 is key to weathering the crisis

May 19, 2020 Rentschler Biopharma extends its cell line development (CLD) solutions for difficult-to-express proteins

Horizon Discovery’s CHOSOURCE platform to be combined with Rentschler Biopharma’s novel in-house process

May 18, 2020 The Smart Workplace at Rentschler Biopharma

What are the key elements defining smart workplaces at a biopharma CDMO?

April 27, 2020 Rentschler Biopharma’s COVID-19 Response

Reliable delivery of essential therapeutics is our top priority

March 16, 2020 A vision for achieving worldwide biopharmaceutical CDMO leadership

CEO Frank Mathias’ article on Strategy 2025

March 9, 2020 Competitive advantages through pharmaceutical formulations

Pharmind article about the Industry survey that predicts increasing investment in formulation development

March 9, 2020 Securing continuous material supply for biopharmaceutical manufacturing

Interview with Matthias Walter in the “Best in Procurement” Magazine

February 18, 2020 “CDMO and Innovation Center”- Ralf Otto Interview in Genetic Engineering & Biotechnology News about our smart U.S subsidiary

The futuristic facility will focus on process innovation and the production of designer biologics

February 18, 2020 Outsourcing Services: from Gene to Patient

CEO Frank Mathias in ChemManager Interview

February 13, 2020 Rentschler Biopharma Adds Senior Executive to Growing U.S. Team

Grace Kim joins as Vice President Business Development – North America and APAC

November 6, 2019 Rentschler Biopharma Kicks off Expansion at U.S. Facility in the Boston Biotech Hub

New 500 L bioreactor in operation mid-2020 at U.S. site
Company’s clinical and commercial manufacturing capabilities to be showcased during BIO-Europe, November 11-13 in Hamburg, Germany

October 28, 2019 Nikolaus F. Rentschler and Frank Mathias are "EY Entrepreneur of the Year"

Rentschler Biopharma management duo received the award on October 25

October 10, 2019 Rentschler Biopharma Announces Appointment of Karen Savage to Milford Area Chamber of Commerce Board of Directors

Vice President Milford Karen Savage joins the Board of the Milford Area Chamber of Commerce

October 9, 2019 Rentschler Biopharma is once again featured on Germany’s top-ranked employers list

Rentschler Biopharma for the second year in a row ranks among the best employers in the biotechnology sector by "Germany's most attractive employer" of the F.A.Z.-Institute.

October 4, 2019 Rentschler Biopharma Announces Enhanced Collaboration with Summit Pharmaceuticals International Corporation to Expand Japanese Operation-Base

Company also announces participation in BioJapan 2019, one of Asia’s largest partnering events for the global biotechnology industry, October 9-11, 2019 in Pacifico Yokohama

September 18, 2019 Rentschler Biopharma is finalist for "EY Entrepreneur of the Year 2019"

Rentschler is among the 38 companies that have made it to the final round of the coveted Entrepreneur Award

September 4, 2019 Rentschler Biopharma to highlight new U.S. facility and bioprocessing expertise at Biotech Week Boston

Major presence at BioProcess International (BPI) Conference, September 9-12 during Biotech Week Boston. Focus on Company’s manufacturing and process development innovations with potential to significantly improve timelines and efficiency

August 28, 2019 Rentschler Biopharma is part of image video “Medical Biotechnology in Germany”

Germany is “the place to be” for innovative solutions and research services in the medical biotechnology field.

June 26, 2019 New Report "Medical Biotechnology in Germany 2019" published

Biopharmaceuticals set a new record: there were 38 approvals in 2018, as many as in the previous two years combined.

June 13, 2019 Making Downstream Processing Continuous and Robust

Scientists of Rentschler Biopharma participated in a virtual roundtable for the Bioprocess International magazine

May 28, 2019 Interview with our CEO Dr. Frank Mathias on the expansion to USA

Die Rentschler Biopharma SE sets foot in the U.S.

May 24, 2019 Driving innovation to support strategic client partnerships

New Article published by our SVP Business Development Federico Pollano

March 31, 2019 Early stage development of avanced formulations in the drug development process provides competitive advantages

Survey "Formulation in the Drug Product Development Process" predicts that drug product formulation recognition and budgets will increase significantly.

March 13, 2019 Rentschler Biopharma sets foot in the U.S. to strengthen its world-class CDMO position

An article written by our SVP Business Development Federico Pollano for the Q1 issue of pharma’s almanac

February 28, 2019 Article on smart medicine published in Plattform Life Sciences

"Chances of digitalization" by Wolfram Schulze and Tobias Rother

January 29, 2019 Rentschler Biopharma SE appoints Dr. Christian Hunzinger as Senior Vice President Project Management

Rentschler Biopharma SE announced today the appointment of Dr. Christian Hunzinger as the new Senior Vice President Project Management, effective from January 15, 2019.

January 3, 2019 Rentschler Biopharma Completes Acquisition of U.S. Manufacturing Site

Rentschler Biopharma SE announced that the Company has completed the acquisition of a manufacturing facility from an affiliate of Shire plc.

December 20, 2018 Rentschler Biopharma SE appoints Henning Gerschewski as Vice President Manufacturing Science and Technology

Rentschler Biopharma SE announced that Henning Gerschewski will join the company as Vice President Manufacturing Science and Technology, effective January 01, 2019.

December 17, 2018 Rentschler Biopharma SE to Purchase U.S. Manufacturing Site from Shire plc

Rentschler Biopharma SE to Purchase U.S. Manufacturing Site from Shire plc

December 13, 2018 Rentschler Biopharma SE appoints Biopharmaceutical Development Expert Dr. Jesús Zurdo as Senior Vice President Process Science and Innovation

Rentschler Biopharma SE announced that Dr. Jesús Zurdo will join the company as SVP Process Science and Innovation, effective January 01, 2019.

November 6, 2018 Informa 2018 Survey predicts Drug Product Formulation Recognition and Budgets to increase significantly

Rentschler Biopharma SE and LEUKOCARE AG reported results from their joint publication of the 2018 Survey ‘Formulation in the Drug Product Development Process’, based on research from Informa Pharma Intelligence.

October 24, 2018 Interview with Michael Scholl of Leukocare

"Formulation matters"

October 18, 2018 Rentschler Biopharma and LEUKOCARE to announce findings of international Drug Product Formulation Survey at BIO-Europe 2018

The survey provides latest insights into the status quo and future of drug product formulation and its potential to refine all steps in the biopharmaceutical value chain.

September 25, 2018 Exciting lectures and stimulating exchange at the 5th Laupheim Biotech Days

The 5th Laupheim Biotech Days, a bi-annual, two-day event organized by Rentschler Biopharma, took place in Laupheim, Germany on September 20th and 21st, 2018.

September 14, 2018 2017 was another record year for medical biotechnology in Germany

The latest biotech report from vfa bio and the Boston Consulting Group on the state of medical biotechnology in Germany is now available

August 31, 2018 Interview with our Federico Pollano

Combining established and novel technologies

August 15, 2018 Interview in CHEManager with Dr. Frank Mathias, CEO of Rentschler Biopharma

Quality from Upper Swabia - claiming technology leadership in the pharmaceutical business

June 28, 2018 Article in European Biotechnology Magazine Summer 2018 „Combining established and novel technologies”

An interview with Federico Pollano, SVP Business Development

June 22, 2018 Article published in the Pharma’s Almanac, June 7, 2018

“Biopharma CDMO success requires technical leadership and problem-solving capabilities”
by Federico Pollano, Senior Vice President Business Development, Rentschler Biopharma SE

June 1, 2018 Article in Journal of Biotechnology, May 2, 2018

“Multiple functions of caprylic acid-induced impurity precipitation for process intensification in monoclonal antibody purification”
by Anja Trapp, Alexander Faude, Natalie Hörold, Sven Schubert, Sabine Faust, Thilo Grob, Stefan Schmidt

May 18, 2018 Customer focus as a growth strategy

Interview with Federico Pollano in the special issue of the transkript to BIO 2018

May 11, 2018 How Rentschler Biopharma is facing the future

Presentation of Rentschler Biopharma's "Strategy 2025" at the Swiss Biotech Day 2018

April 26, 2018 Impressions from the Deutschen Biotechnologietage 2018 in Berlin

With a record attendance of more than 1000 participants, the 9th German Biotechnology Days took place in Berlin on April, 18th and 19th 2018.

April 25, 2018 Rentschler Biopharma is preparing for the future

Rentschler Biopharma's CEO is presenting at the Swiss Biotech Day 2018

April 13, 2018 Think Big at the “Deutsche Biotechnologietage 2018” in Berlin

Focus on Biotech in Germany

April 5, 2018 Impressions from the BIO-Europe Spring in Amsterdam

Together with our strategic partners Leukocare AG and Rentschler Fill Solutions, we are looking back on very successful days at BIO-Europe Spring from March 12 to 14, 2018 in Amsterdam.

April 3, 2018 Our latest publication on Bioprocess Online, February 23, 2018

“Modular approaches for diverse molecules: reinventing smart bioprocessing”

March 28, 2018 Rentschler Biopharma SE hires Dr. Thomas Rösch as Vice President Biopharma Engineering & Technology

Rentschler Biopharma SE announced that Dr. Thomas Rösch will join the Company as Vice President Biopharma Engineering & Technology, effective April 1, 2018.

March 26, 2018 Publication in Pharm. Ind. 80, No. 2 (2018)

“Biopharmaceutical manufacturing in single-use bioreactors” by Tina Lütke-Eversloh and Peter Rogge

March 16, 2018 Join Rentschler Biopharma at the BPI West 2018

We kindly invite you to meet us at this year’s BioProcess International West conference in San Francisco, CA from March, 19th to 22nd 2018.

March 15, 2018 A streamlined mAb platform process will be presented at the Bioprocessing Summit Europe 2018

Integration of single-use adsorptive filtration as a unit operation for virus clearance

March 13, 2018 “Transkript persönlich” presents Dr. Ralf Otto

In the March issue of the German magazine Transkript, Dr. Ralf Otto, the new COO of Rentschler Biopharma SE, gives a short insight into his life in- and outside of his office.

March 9, 2018 Rentschler Biopharma and Leukocare demonstrate success of strategic alliance for biopharmaceutical development and formulation

First year of alliance delivers project wins – including four with US-based clients – proving effectiveness of new strategy

March 8, 2018 Meet Rentschler Biopharma at the BIO-Europe Spring in Amsterdam

We warmly invite you to meet us at the BIO-Europe Spring in the RAI Convention Center in Amsterdam from the 12th to 14th of March.

February 28, 2018 Rentschler Biopharma SE appoints Federico Pollano as Senior Vice President, Business Development

Rentschler Biopharma SE announced that Federico Pollano has joined the Company as Senior Vice President, Business Development, effective March 1, 2018.

January 31, 2018 Rentschler Biopharma SE appoints international biopharma expert Dr. Ralf Otto as Chief Operating Officer

Rentschler Biopharma SE appointed Dr. Ralf Otto as Chief Operating Officer (COO), effective February 1, 2018.

January 29, 2018 Presentation about design, structure, and manufacturability of fusion proteins at PepTalk 2018

Improved manufacturability of designed proteins

January 18, 2018 Article in Laborwelt 2017

“Expensive affinity purification”

January 3, 2018 Presentation about smart bioprocessing strategies for fusion proteins at PepTalk 2018 in San Diego, CA

“Design, structure and manufacturability: Lessons learned from fusion proteins”

December 1, 2017 Presentation of a novel approach for antibody purification at the PEGS Europe 2017

Caprylic acid-induced precipitation as beneficial tool for mAb purification design

November 29, 2017 Article in Bioprocess International Vol 15, Issue 10, November 2017

"Antibody–Drug Conjugates: Fast-Track Development from Gene to Product"

November 13, 2017 Rentschler Biopharma and its partners collectively presented themselves at BIO-Europe

Full-service at the highest quality level

November 7, 2017 Article in American Pharmaceutical Review October 2017

"Strategies to Predict the Developability of Biopharmaceuticals"

November 3, 2017 Rentschler Biopharma will present at the PEGS Europe Summit 2017

Presenting a novel approach for antibody purification

October 23, 2017 Invitation to meet Rentschler Biopharma at BIO-Europe 2017 in Berlin

World-class biomanufacturing solutions and delicious fruit juices

October 20, 2017 Great interest in CDMO Services at the BioJapan 2017

Successful conversations and speedy portraits at the Rentschler Biopharma booth

October 17, 2017 Article in European Biotechnology, Autumn 2017

"Advanced formulations for biopharmaceuticals"

October 16, 2017 Article in Bioprocess International Vol 15, Issue 8, Featured Report, September 2017

“Controlling Glycosylation in Fusion Protein Manufacturing to Generate Potent Biobetters”

October 6, 2017 Participation at two European Biotech events

Next-generation technologies and products

October 4, 2017 Rentschler Biotechnologie GmbH announces transition into a European corporation called Rentschler Biopharma SE

Rentschler Biotechnologie GmbH has successfully transitioned into a European corporation (SE) on October 1, 2017. The Company is operating as Rentschler Biopharma SE with immediate effect.

October 2, 2017 Meet Rentschler Biopharma at BioJapan 2017

Receive a personal portrait by our caricaturist

September 14, 2017 Invitation to meet Rentschler at BioProcess International 2017

Rentschler is pleased to announce its participation in the BioProcess International Conference and Exhibition, taking place from September 25 - 28, 2017 at the Hynes Convention Center in Boston, MA.

September 6, 2017 CDMOs are champions for customization of single-use equipment

Inspiring presentation at The Bioprocessing Summit in Boston, MA

September 4, 2017 Scientific Formulation Seminar & Workshop at the IZB in Martinsried

Advantages of the strategic alliance of Rentschler and Leukocare will be presented

August 18, 2017 Presenting experience with single-use systems at the BioProcessing Summit in Boston, MA

Lecture on “Disposables in bioprocessing: Catalogue or customization?”

August 14, 2017 Minister for Economic Affairs of Baden-Württemberg visits Rentschler

In the beginning of August, Rentschler hosted a meeting with Dr. Nicole Hoffmeister-Kraut, Minister of Economic Affairs, Labour and Housing of Baden-Württemberg

August 7, 2017 Rentschler is growing continuously

Growth is driven by the international market

July 10, 2017 Participation at the Annual Meeting on Continuous Biomanufacturing in Oxford, UK

Presentation about single-use trends in development and manufacturing

June 30, 2017 Intensive networking at the top event of the biotechnology industry

Rentschler presented itself at the BIO International Convention 2017

June 13, 2017 Rentschler Biotechnologie and Rentschler Fill Solutions announce strategic partnership for one-stop solutions with new state-of-the-art fill and finish facilities

Rentschler Biotechnologie GmbH and Rentschler Fill Solutions GmbH announced a strategic partnership

June 6, 2017 Participation at the BIO International Convention in San Diego, CA, USA

Invitation to visit the Rentschler booth No 1929

May 29, 2017 A keen interest in current trends in cell culture at the 25th ESACT meeting in Lausanne

From May 14 to 17, 2017 more than 1,000 participants met for the 25th meeting of the European Society for Animal Cell Technology (ESACT) in Lausanne, Switzerland

May 8, 2017 Invitation to attend Rentschler’s presentations at the 25th ESACT meeting in Lausanne

The 25th Meeting of the European Society for Animal Cell Technology (ESACT) will be held from 14th to 17th May 2017 in Swisstech Convention Center, Lausanne, Switzerland

May 5, 2017 Participation at 13th Annual PEGS Boston Summit 2017

Presentation on fusion protein approaches to generate biobetter drugs

April 3, 2017 Rentschler/Leukocare alliance as main topic at the BIO-Europe Spring

Exhibition booth at BIO-Europe Spring in Barcelona, Spain

March 27, 2017 Article in European Biopharmaceutical Review April 2017

“Seize the Market”

March 22, 2017 Article in Bioprocess International. Vol 15, Issue 3, March 2017

“Drivers, Opportunities, and Limits of Continuous Processing”

March 16, 2017 Participation at the Bio-Europe Spring in Barcelona, Spain

Invitation to visit the Rentschler booth No 55.

February 2, 2017 Rentschler and Leukocare announce strategic alliance and equity investment

Rentschler Biotechnologie GmbH, Laupheim and Leukocare AG, Martinsried today announced a strategic alliance.

January 31, 2017 Article in Bioprocess International 14 January 2017 Featured Report

"Single-Use Depth Filters - Application in Clarifying Industrial Cell Cultures"

January 24, 2017 Article in American Pharmaceutical Review. Vol 20, Issue 1, Jan/Feb 2017

“Production Challenges for Complex Biologics: Fusion Proteins”

January 16, 2017 Rentschler well-represented at PepTalk 2017

Expertise in innovative protein formats highlighted in three presentations

November 18, 2016 Invitation to talk business and enjoy fruit smoothies at Bio-Europe 2016

Rentschler joined the leading European biotech business conference

November 4, 2016 Rentschler expands cGMP manufacturing capacity following increased international demand

Second 2,000 liter single-use bioreactor put into operation. Further capacity expansion only a few weeks after putting into operation an innovative Twin system.

November 2, 2016 Participation at the Bio-Europe in Cologne, Germany

Invitation to visit the Rentschler booth No 11/12

October 20, 2016 Article in World Pharma, Vol. 2, 2016

"A proud history of progress through biotechnology"

September 16, 2016 Rentschler doubles manufacturing capacity to address growing demand for biopharmaceuticals

Innovative Twin system with two 3,000 liter bioreactors and associated downstream processing equipment put into operation. Second significant expansion in one year.

September 15, 2016 Rentschler Media Day

Rentschler has invited to a Media Day at Laupheim

September 1, 2016 Article in American Pharmaceutical Review. Vol 19, Issue 5, Jul/Aug 2016

"The Benefits and Limits of Disposable Technologies In Manufacturing Protein Therapeutics"

July 14, 2016 Presentation of Dr. Frank Mathias at the Biotech Press Lounge

Press Event of IZB and BioM at Martinsried near Munich

July 11, 2016 Rentschler was actively involved in top-class protein purification conference

Participation at the “Recovery XVII” in June

July 6, 2016 Rentschler again as an exhibitor at the BIO International Convention

Artist at the booth attracted many visitors

June 17, 2016 Successful talks of drug developers, technology providers and academia at the 4th Laupheim Biotech Days

Topic: Fusion Proteins - delivering novel therapeutic options

June 1, 2016 Participation at the BIO International Convention 2016 in San Francisco

Invitation to visit the Rentschler booth #923

April 29, 2016 Rentschler Presentations at the BPI West 2016 in Oakland, CA

Rentschler’s Turbocell™ platform and single-use vs. stainless steel decision process

February 17, 2016 Participation in 15th Annual PepTalk Protein Science Week 2016

Presentation regarding the cost constraints in therapeutic protein manufacturing

February 15, 2016 Rentschler appoints new CFO

Rentschler appoints Stefan Rampf to the position of CFO

January 29, 2016 Article in BioProcess International, Supplement Dec 2015

"The Single-Use or Stainless Steel Decision Process"

January 7, 2016 Rentschler appoints new Chief Executive Officer

Dr. Frank Mathias to become CEO of Rentschler Biotechnologie

December 15, 2015 Rentschler announces 4th Laupheim Biotech Days

The biennial scientific conference is taking place from June 13 to 14, 2016

November 30, 2015 Participation in PEGS Europe 2015

Rentschler presented at one the most important protein therapeutics development and manufacturing meetings in Europe

October 7, 2015 Probiodrug and Rentschler sign manufacturing agreement

Probiodrug signs agreement with Rentschler for manufacture of its pGlu-Abeta targeting antibody PBD-C06

October 2, 2015 Article in the European Biotechnology, Autumn Edition 2015

"Value-adding perfusion-based biomanufacturing"

September 4, 2015 The Seventh Annual Bioprocessing Summit in Boston from 3rd to 7th August 2015

Rentschler presented expertise with process platforms and modular configured processes to express and purify therapeutic Proteins

August 12, 2015 Rentschler is responsible for providing cGMP drug substance of DX-2930 for Dyax Corp.

Client News: Dyax Corp. announced today
Dyax Corp. Provides Update on DX-2930 Clinical and Commercial Supply Initiatives

June 22, 2015 Participation in PEGS Summit 2015

Rentschler presented at the essential protein engineering summit in Boston

March 23, 2015 Rentschler commissions new 2,000L single-use bioreactor

Total single-use production capacity doubled

March 2, 2015 Article in BioProcess International, Feb 2015

"Evaluating Adsorptive Filtration As a Unit Operation for Virus Removal"

January 8, 2015 Article in European Biotechnology Winter Edition 2014

"Increasing manufacturability with a modular approach"

November 26, 2014 Article in Manufacturing Chemist, Oct 2014

"Employing new single-use technology in bioprocesses"

October 16, 2014 Article in European Biotechnology, Autumn Edition 2014

"Taking mAb purification to the next level"

September 19, 2014 Rentschler presentation at The Sixth Annual Bioprocessing Summit in Boston

Highlights of the latest conference in Boston

July 16, 2014 Article in transkript, Jul/Aug 2014

"Single-Use-Bioprocesses - Hype or Future-Technology?"

June 20, 2014 Rentschler invests EUR 24 million in stainless steel bioreactor manufacturing

Rentschler announces the building of a Twin system with two 3,000 Liter stainless steel bioreactors mainly targeting market supply

June 10, 2014 Rentschler Expands Single-Use Manufacturing Capacities

2,000 L single-use bioreactor is planned to be in operation by the beginning of 2015.

May 30, 2014 ACTIP Meeting from 12th to 13th May in Copenhagen

Top-class exchange of experiences on the topics “Glycoengineering - Better Cells for Better Products” and “Challenges with Single Use Equipment”

May 27, 2014 Article in BioProcess International, Apr 2014

"High-Cell-Density Clarification By Single-Use Diatomaceous Earth Filtration"

May 27, 2014 Participation in Single Use Biomanufacturing III and in PEGS Summit

Rentschler presentations at conferences in London and Boston

April 15, 2014 Guest lectures at colleges and universities

Rentschler promotes the education of the next generation

March 21, 2014 Presentations at Peptalk and at Cell Line Development & Engineering

Participation in international conferences and presentations of experiences and results from technology development and production.

March 14, 2014 Rentschler announces 3. Laupheimer Zelltage

“Processes for Virus-based Biologics” is the focus of this year´s 3. Laupheimer Zelltage, which will be held from June 2-3.

March 10, 2014 Article in transkript, Mar 2014

Platform technology and individual process, time-saving and cost-effective tachniques are required